Arrowhead Pharma scores $673M drug deal

California-based Arrowhead Pharmaceuticals, which has about 100 employees in Madison, signed a deal totaling $673 million with Amgen, one of the world’s largest biotechnology companies, to bring two drugs to market for the treatment of cardiovascular disease.